Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Natural killer cell deficiency should be considered in patients susceptible to herpes virus or papillomavirus with persistently decreased NK cell function.

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Cellistic introduces Echo-NK Platform to enable scalable manufacturing of allogeneic cell therapies to target multiple diseases: Mont-Saint-Guibert, Belgium Monday, April 14, 2025 ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

The bone marrow environment evolves in ways that support the cancer, and I’m a firm believer that to treat cancer effectively ...

Natural Killer (NK) cells are increasingly leveraged in these therapies for their ability to destroy harmful cancerous cells in their early stages, making them a promising option for the treatment of ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...